Ginger Graham

Ginger Graham teaches a course in entrepreneurship at the Harvard Business School and consults to first-time CEO’s in the areas of leadership, strategy, board-effectiveness, and organization building. She is the former President and Chief Executive Officer of Amylin Pharmaceuticals, a biopharmaceutical company based in San Diego, CA, focused on diabetes and obesity. During Ginger’s tenure at Amylin, the company launched two first-in-class medicines for people with diabetes, was listed on the Nasdaq 100 and was rated as one of the Top 10 places in the industry for scientists to work. Prior to her time at Amylin, Ginger was Group Chairman, Office of the President for Guidant Corporation. Ginger has received numerous awards and honors including being named as the Emerging Company Executive of the Year by the Global Health Council in 2005, a Finalist in Marketwatch’s CEO of the Year in 2006, and named as the American Diabetes Association’s Woman of Valor award in 2006. Ginger was the first woman CEO named to the PhRMA Board and Executive Committee. Ms. Graham serves on the Boards of Directors for Walgreen Co., Genomic Health, Inc., Proteus Biomedical, ICAT Managers, and the American Diabetes Association Research Foundation where she serves as Vice Chair. She serves on numerous public and private advisory boards, and frequently speaks at business schools and has written for Harvard Business Review. Ginger received a B.S. in agricultural economics from the University of Arkansas, and holds an MBA, with distinction, from Harvard University.